systemic sclerosis-associated interstitial lung disease (SSc-ILD)
Part of Respiratory diseases
🏥1Companies
Companies in systemic sclerosis-associated interstitial lung disease (SSc-ILD)
Note, this image was autogenerated by Syggy based on what we know about the company. It is not an official company publication.
Acceleron
Cambridge, Massachusetts, United States
Acceleron was a biopharmaceutical therapies company acquired by Merck in 2021.
Business ModelB2B, focused on discovery, development, and commercialization of biotherapeutics, generating revenue through collaboration, licensing, and research arrangements with partners like Celgene (now Bristol Myers Squibb).
Core TechExploiting the therapeutic potential of the transforming ...
Funding$493.0M
Founded2003
Drug Discovery/Development
59
Related Companies
Semantically similar companies discovered by AI
B
Breathing Better With Us !
BREATHING-A simple thing, taken for granted, but the most precious thing in the World
Pulmonary/ Asthma
3
Pliant Therapeutics
South San Francisco, CA, United States
Pliant Therapeutics is a company developing treatments for fibrotic diseases.
Business ModelClinical-stage Biopharmaceutical
Core TechProprietary integrin discovery platform
Funding$1.1B
Founded2015
Drug Discovery/Development
Too Big!
K
Kivo Health
San Francisco, CA, USA
Virtual care company for chronic lung disease patients offering a Medicare-covered program to improve symptoms and lower costs.
...moreBusiness ModelB2B2C
Core TechTelehealth + AI
Founded2023
Telehealth/Virtual Care✓Source: Y Combinator
13
